Fisher Wallace Laboratories
Fisher Wallace Laboratories, Inc., headquartered in New York City, markets the Fisher Wallace Stimulator, a cranial electrotherapy stimulation (CES) device. The company was founded in 2007 by entrepreneur Charles Avery Fisher, son of electronics pioneer Avery Fisher, and Martin Wallace. The company acquired its lead product from Saul and Bernard Liss in 2006. Inc. magazine rated the company as being #983 (in 2014) and #1447 (in 2015) in its "Inc. 5000" listing. The Lisses had already obtained 510K marketing clearance from the Food and Drug Administration to treat anxiety, depression, and insomnia when Fisher-Wallace acquired it.
primaryTopic
Fisher Wallace Laboratories
Fisher Wallace Laboratories, Inc., headquartered in New York City, markets the Fisher Wallace Stimulator, a cranial electrotherapy stimulation (CES) device. The company was founded in 2007 by entrepreneur Charles Avery Fisher, son of electronics pioneer Avery Fisher, and Martin Wallace. The company acquired its lead product from Saul and Bernard Liss in 2006. Inc. magazine rated the company as being #983 (in 2014) and #1447 (in 2015) in its "Inc. 5000" listing. The Lisses had already obtained 510K marketing clearance from the Food and Drug Administration to treat anxiety, depression, and insomnia when Fisher-Wallace acquired it.
has abstract
Fisher Wallace Laboratories, I ...... d called for an investigation.
@en
Link from a Wikipage to an external page
Wikipage page ID
45,661,660
page length (characters) of wiki page
Wikipage revision ID
994,425,177
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
subject
hypernym
type
comment
Fisher Wallace Laboratories, I ...... en Fisher-Wallace acquired it.
@en
label
Fisher Wallace Laboratories
@en